B

바이오스마트

038460KOSDAQ전자부품 제조업

59.5 / 100

Reference Date: 2026-04-13

Financial Score24.0 / 40
News Sentiment12.5 / 25
Momentum13.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but the high debt ratio poses financial risk. Declined 6.4% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

BioSmart operates diverse business segments including smart card manufacturing, pharmaceuticals, alcohol payment solutions, heavy electrical equipment, and publishing, leveraging cross-industry synergies for sustainable growth. The heavy electrical/electrical products segment contributes the highest revenue share, followed by smart card and pharmaceutical businesses.

Number of Employees

168people

Average Salary

57.0M KRW

Score Calculation Basis

Detailed Financial Score

PER
12.16Industry Average 21.846.5Point

Lower than industry avg (good)

PBR
0.60Industry Average 1.237.0Point

Half of industry avg (excellent)

ROE
5.22Industry Average 4.684.0Point

In line with industry avg

Debt Ratio
17.05Industry Average 10.870.5Point

1.6x industry avg (risky)

Trend 2023~20256.0 / 10 points
Revenue Growth Rate
1.0 / 3

Avg ▲2.9% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲56.1% (2-year basis)

ROE Trend
2.0 / 4

Avg ROE 7.0% (declining, 3yr)

Detailed News Sentiment

2 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position5.0Point

52w mid range (46%)

Current 4,330Won52-week high 6,25052-week low 2,670
1-month return2.0Point

1m -6.38% (slight drop)

Volume trend6.0Point

Volume increasing

Detailed Disclosure

6 totalPositive 0Neutral 6Negative 0
  • Neutral주식등의대량보유상황보고서(약식)2026-04-09
  • Neutral정기주주총회결과2026-03-27
  • Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-27
  • Neutral감사보고서제출2026-03-19
  • Neutral[기재정정]주식소각결정2026-03-19